Common hair loss disorders

American Family Physician

Volumn 68, Issue 1, 2003, Pages 93-102+107

  Springer, Karyn ^a,b,c,d   Brown, Matthew ^a   Stulberg, Daniel L ^a  

^a Utah Valley Fam Pract Resid Prog   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

^c UTAH VALLEY REGIONAL MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE; FINASTERIDE; HORMONE; MINOXIDIL; RETINOIC ACID; SPIRONOLACTONE;

ALOPECIA; ALOPECIA AREATA; FOOD AND DRUG ADMINISTRATION; FRONTAL LOBE; HAIR GROWTH; HAIR LOSS; HUMAN; MALE TYPE ALOPECIA; REVIEW; TELOGEN EFFLUVIUM; TEMPORAL LOBE; TINEA CAPITIS; TRACTION ALOPECIA; TRICHOTILLOMANIA; WELLBEING;

ALOPECIA; ANTIFUNGAL AGENTS; DIAGNOSIS, DIFFERENTIAL; FLUCONAZOLE; HUMANS; HYPOTRICHOSIS; MINOXIDIL; TINEA CAPITIS; VASODILATOR AGENTS;

EID: 0038156965     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Sperling LC, Mezebish DS. Hair diseases. Med Clin North Am 1998;82:1155-69.
2. Habif TP. Clinical dermatology: a color guide to diagnosis and therapy 3d ed. St. Louis: Mosby, 1996.
3. Sperling LC. Hair and systemic disease. Dermatol Clin 2001;19:711-26.
4. Jackson EA. Hair disorders. Prim Care 2000;27: 319-32.
5. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for androgenetic alopecia. American Academy of Dermatology. J Am Acad Dermatol 1996;35(3 pt 1):465-9.
6. Shapiro J, Price VH. Hair regrowth. Therapeutic agents. Dermatol Clin 1998;16:341-56.
7. Sawaya ME, Shapiro J. Androgenetic alopecia. New approved and unapproved treatments. Dermatol Clin 2000;18:47-61.
8. Bergfeld WF. Retinoids and hair growth. J Am Acad Dermatol 1998;39(2 pt 3):S86-9.
9. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol 1998;39(4 pt 1):578-89.
10. Drake L, Hordinsky M, Fiedler V, Swinehart J, Unger WP, Cotterill PC, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol 1999; 41:550-4.
11. Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W, et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 2000;43(5 pt 1):768-76.
12. Goodheart HP. Hair and scalp disorders. Part 2: Alopecia areata. Womens Health Prim Care 1999; 2:283-7.
13. Bertolino AP. Alopecia areata. A clinical overview. Postgrad Med 2000;107:81-5,89-90.
14. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000;42:549-66.
15. Messinger ML, Cheng TL. Trichotillomania. Pediatr Rev 1999;20:249-50.
16. Rietschel RL. A simplified approach to the diagnosis of alopecia. Dermatol Clin 1996;14:691-5.
17. Christenson GA, Crow SJ. The characterization and treatment of trichotillomania. J Clin Psychiatry 1996;57(Suppl 8):42-7.
18. Alsafwah S, Alzein M. Small bowel obstruction due to trichobezoar: role of upper endoscopy in diagnosis. Gastrointest Endosc 2000;52:784-6.
19. Kemna ME, Elewski BE. A U.S. epidemiologic survey of superficial fungal diseases. J Am Acad Dermatol 1996;35:539-42.
20. Elewski BE. Treatment of tinea capitis: beyond griseofulvin. J Am Acad Dermatol 1999;40(6 Pt 2):S27-30.
21. Headington JT. Cicatricial alopecia. Dermatol Clin 1996;14:773-82.